Related Experiment Videos
Polycystic kidney disease
1Department of Medicine, Division of Nephrology, Mount Sinai School of Medicine, New York, NY 10029, USA. pat.wilson@mssm.edu
The New England Journal of Medicine
|January 9, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Urinary exosome proteomic profiling defines stage-specific rapid progression of autosomal dominant polycystic kidney disease and tolvaptan efficacy.
BBA advances·2023
Same author
Research priorities for autosomal dominant polycystic kidney disease: a UK priority setting partnership.
BMJ open·2022
Same author
Collecting duct cells show differential retinoic acid responses to acute versus chronic kidney injury stimuli.
Scientific reports·2020
Same author
Novel biomarkers in kidney disease: roles for cilia, Wnt signalling and ATMIN in polycystic kidney disease.
Biochemical Society transactions·2016
Same author
Therapeutic targets for polycystic kidney disease.
Expert opinion on therapeutic targets·2015
Same author
Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline.
PloS one·2014
Same journal
Ebola at 50 - Lessons for Outbreak Response and Preparedness.
The New England journal of medicine·2026
Same journal
Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.
The New England journal of medicine·2026
Same journal
Ianalumab plus Eltrombopag in Immune Thrombocytopenia.
The New England journal of medicine·2026
Same journal
Hypertension Control in Low-Income Patients. Reply.
The New England journal of medicine·2026